A BITE-SIZED, MOBILE-COMPATIBLE LEARNING CURRICULUM FOR A NEW INDICATION
CLIENT: MAJOR PHARMACEUTICAL COMPANY
The client expected to receive a new drug indication in the US market for chronic kidney disease. They were also in the process of moving to a new learning platform.
The client needed support developing a highly interactive and engaging learning curriculum specific to a US audience that could also be easily adapted for global use. Materials needed to be optimised to take advantage of the features provided by the new learning platform.
We developed a curriculum based around a series of interactive and engaging mobile-compatible modules that were easy to navigate, visually appealing and contained bite-sized activities for knowledge consolidation and self-assessment
The curriculum incorporated innovative and immersive assets which would make the learning feel more relevant and memorable
The content was developed with ease of future updates and extensions in mind to streamline the review and approval process and provide easily editable content for localisations by other markets
We successfully delivered a high-quality, cohesive curriculum for the new indication, on time and on budget. We received overwhelmingly positive feedback from both the client and the learners.
We created a more engaging and impactful learning journey for the end users and were subsequently awarded additional work with the client as a result of the positive experience